Analysts Conflicted on These Healthcare Names: Iovance Biotherapeutics (IOVA), Amylyx Pharmaceuticals Inc (AMLX) and Vaxcyte (PCVX)
Analysts Offer Insights on Healthcare Companies: Herbalife (HLF), Alignment Healthcare (ALHC) and Vaxcyte (PCVX)
Analysts Are Bullish on These Healthcare Stocks: Vaxcyte (PCVX), Apogee Therapeutics, Inc. (APGE)
Buy Rating Reaffirmed for Vaxcyte Amid Financial Discipline and Promising Vaccine Trials
Buy Rating Affirmed for Vaxcyte Amid Promising Pipeline and Clear Milestones
Vaxcyte Analyst Ratings
Needham Reiterates Buy on Vaxcyte, Maintains $95 Price Target
Needham: Reiterates the Vaxcyte (PCVX.US) rating and adjusted from buy to buy rating, target price is $95.00.
Vaxcyte Analyst Ratings
Needham Reiterates Buy on Vaxcyte, Maintains $95 Price Target
Vaxcyte Analyst Ratings
Buy Rating Affirmed for Vaxcyte on Strong Vaccine Candidate Prospects and Upward Financial Projections
Analysts Offer Insights on Healthcare Companies: Xencor (XNCR) and Vaxcyte (PCVX)
Vaxcyte Analyst Ratings
Buy Rating Affirmed for Vaxcyte Amid Strong Pipeline and Strategic R&D Investment
TD Cowen Remains a Buy on Vaxcyte (PCVX)
Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Vaxcyte (PCVX) and Vertex Pharmaceuticals (VRTX)
Analysts Offer Insights on Healthcare Companies: Vaxcyte (PCVX), HCA Healthcare (HCA) and Sarepta Therapeutics (SRPT)
Analysts Offer Insights on Healthcare Companies: Vaxcyte (PCVX), Xeris Pharmaceuticals (XERS) and IN8bio (INAB)
Strong Buy Rating for Vaxcyte Amidst Promising Advancements and Strategic Positioning
No Data